A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults

NCT04268420 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

46

Enrollment

FED

Sponsor class

Conditions

Vaccine Reaction

Interventions

DRUG: FMP013
DRUG: ALFQ

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]